The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target

Published:2014-07-31 Issue:11 Volume:18 Page:1305-1313
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Liu Wen-Yue,Huang Sha,Shi Ke-Qing,Zhao Chen-Chen,Chen Li-Li,Braddock Martin,Chen Yong-Ping,Feng Wen-Ke,Zheng Ming-Hua

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728222.2014.944898

Reference79 articles.

1. Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor γ and Altered Metabolic States

2. Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases

3. Identification of a novel FGF, FGF-21, preferentially expressed in the liver

4. Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue

5. Time-imposed daily restricted feeding induces rhythmic expression of Fgf21 in white adipose tissue of mice

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic evaluation of the novel FGF21 analogue DC2303 for metabolic dysfunction-associated steatohepatitis;2024-08-26

2. Fibroblast growth factor 21 is associated with widening QRS complex and prolonged corrected QT interval in patients with stable angina;BMC Cardiovascular Disorders;2022-09-30

3. Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study;Frontiers in Cardiovascular Medicine;2022-03-16

4. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children;Molecular Genetics and Metabolism;2022-01

5. FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention;Cancers;2021-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3